Company intelligence / Profile preview
TabQ Therapeutics
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
Overview
TabQ Therapeutics is commercially active, marketing a diverse portfolio of oral pharmaceuticals and supplements targeting common chronic ailments, with a particular focus on pain, bone health, diabetes, and cardiovascular conditions; clinical results are not explicitly reported but commercial activity and wide adoption are noted.
- Therapeutic areas
- EndocrinologyGastroenterologyHematologyCardiovascularOtherNeurology
- Modalities
- Small moleculeCalcium supplementFood supplement
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on TabQ Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TabQ Therapeutics.